We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.45B
AUM Growth
+$91.7M
Cap. Flow
-$34M
Cap. Flow %
-2.34%
Top 10 Hldgs %
38.91%
Holding
217
New
7
Increased
36
Reduced
127
Closed
14

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$2.91M
2
MDT icon
Medtronic
MDT
+$2.84M
3
PRGO icon
Perrigo
PRGO
+$2.61M
4
TER icon
Teradyne
TER
+$1.71M
5
TJX icon
TJX Companies
TJX
+$1.61M

Sector Composition

Rank Sector Weight
1 Technology 25.94%
2 Healthcare 25.6%
3 Industrials 15.08%
4 Consumer Discretionary 10.81%
5 Communication Services 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$130B
$1.71M 0.12%
24,714
-776
-3% -$54.7K
TYL icon
77
Tyler Technologies
TYL
$13B
$1.66M 0.11%
4,683
-75
-2% -$24.4K
IJH icon
78
iShares Core S&P Mid-Cap ETF
IJH
$128B
$1.49M 0.1%
29,735
-40
-0.1% -$2.04K
CSCO icon
79
Cisco
CSCO
$488B
$1.48M 0.1%
28,287
-13,422
-32% -$655K
PFE icon
80
Pfizer
PFE
$150B
$1.45M 0.1%
35,503
+3,117
+10% +$135K
ISRG icon
81
Intuitive Surgical
ISRG
$142B
$1.29M 0.09%
5,043
-521
-9% -$128K
AMAT icon
82
Applied Materials
AMAT
$435B
$1.27M 0.09%
10,340
-25
-0.2% -$2.87K
VRTX icon
83
Vertex Pharmaceuticals
VRTX
$133B
$1.25M 0.09%
3,972
+2,547
+179% +$764K
VZ icon
84
Verizon
VZ
$195B
$1.24M 0.09%
31,813
-1,731
-5% -$68.3K
CSX icon
85
CSX Corp
CSX
$92.8B
$1.21M 0.08%
40,360
+900
+2% +$27.7K
SPGI icon
86
S&P Global
SPGI
$121B
$1.18M 0.08%
3,430
NVST icon
87
Envista
NVST
$4.61B
$1.18M 0.08%
28,802
+645
+2% +$24.5K
ZTS icon
88
Zoetis
ZTS
$30.4B
$1.13M 0.08%
6,804
-475
-7% -$77.8K
MTD icon
89
Mettler-Toledo International
MTD
$28.8B
$1.13M 0.08%
738
+75
+11% +$113K
IWP icon
90
iShares Russell Mid-Cap Growth ETF
IWP
$21B
$1.12M 0.08%
12,288
-118
-1% -$10.5K
GIS icon
91
General Mills
GIS
$20.4B
$1.1M 0.08%
12,820
+200
+2% +$16K
MELI icon
92
Mercado Libre
MELI
$92.7B
$1.02M 0.07%
777
-23
-3% -$26.2K
RTX icon
93
RTX Corp
RTX
$300B
$1.01M 0.07%
10,288
-341
-3% -$33.6K
RVTY icon
94
Revvity
RVTY
$13.2B
$961K 0.07%
7,215
+601
+9% +$79.2K
NSC icon
95
Norfolk Southern
NSC
$75.3B
$861K 0.06%
4,060
-554
-12% -$128K
CRSP icon
96
CRISPR Therapeutics
CRSP
$5.22B
$855K 0.06%
+18,904
New +$918K
IVV icon
97
iShares Core S&P 500 ETF
IVV
$904B
$845K 0.06%
2,056
-272
-12% -$109K
PANW icon
98
Palo Alto Networks
PANW
$315B
$845K 0.06%
8,460
-1,100
-12% -$93.2K
TGT icon
99
Target
TGT
$69.9B
$835K 0.06%
5,044
-585
-10% -$96.2K
IDXX icon
100
Idexx Laboratories
IDXX
$45B
$825K 0.06%
1,650
-148
-8% -$70.8K

Similar funds

Reynders McVeigh Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Reynders McVeigh Capital Management held 217 positions worth $1.45B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Reynders McVeigh Capital Management's Q1 2023 filing shows 7 new, 36 increased, 127 reduced and 14 closed positions. Its largest new stake was Perrigo: 72,303 shares worth $2.59M. The largest sale was Apple, an estimated $3.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Reynders McVeigh Capital Management's largest Q1 2023 buy was Perrigo: 72,303 shares worth $2.59M.
  • Reynders McVeigh Capital Management added most to Aptiv in Q1 2023, an estimated $2.91M increase.
  • Reynders McVeigh Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $3.9M.
  • Reynders McVeigh Capital Management fully exited AstraZeneca in Q1 2023, selling an estimated $651K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 39% of its $1.45B portfolio in Q1 2023.
  • Reynders McVeigh Capital Management opened 7 new positions and closed 14 in Q1 2023.
  • Reynders McVeigh Capital Management's portfolio value rose 6.7% quarter-over-quarter to $1.45B.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2023, filed 3 May 2023.